No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
8-K: Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update
10-Q: Quarterly report
10-K/A: Annual report (Amendment)
10-K: FY2024 Annual Report
10-Q: Q2 2024 Earnings Report
TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update
Unlock the Full List